HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xinyi Liu Selected Research

tracheloside

9/2022Multi-target tracheloside and doxorubicin combined treatment of lung adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xinyi Liu Research Topics

Disease

36Neoplasms (Cancer)
07/2022 - 10/2008
9Breast Neoplasms (Breast Cancer)
12/2022 - 02/2008
6Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2022 - 11/2019
5Rheumatoid Arthritis
01/2021 - 01/2019
5Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 11/2016
4Lung Neoplasms (Lung Cancer)
09/2022 - 02/2021
4Carcinogenesis
07/2021 - 01/2017
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2021 - 06/2020
4Starvation
01/2021 - 01/2019
4Hepatocellular Carcinoma (Hepatoma)
01/2020 - 03/2015
3Asthma (Bronchial Asthma)
06/2022 - 11/2019
3Squamous Cell Carcinoma of Head and Neck
01/2022 - 01/2019
3Colonic Neoplasms (Colon Cancer)
10/2021 - 12/2016
3Frailty
05/2021 - 05/2020
3Prostatic Neoplasms (Prostate Cancer)
02/2021 - 08/2014
3Pancreatic Neoplasms (Pancreatic Cancer)
02/2021 - 10/2008
3Alzheimer Disease (Alzheimer's Disease)
01/2021 - 10/2013
2Adenocarcinoma of Lung
09/2022 - 01/2022
2Autoimmune Diseases (Autoimmune Disease)
01/2022 - 11/2019
2Wounds and Injuries (Trauma)
04/2021 - 10/2009
2Urinary Bladder Neoplasms (Bladder Cancer)
02/2021 - 09/2016
2Glioma (Gliomas)
02/2021 - 01/2018
2COVID-19
01/2021 - 01/2020
2Neoplasm Metastasis (Metastasis)
01/2020 - 01/2012
2Necrosis
01/2019 - 10/2009
2Hemolysis
11/2018 - 12/2016
2Endometrial Neoplasms (Endometrial Cancer)
07/2017 - 03/2016
1Head and Neck Neoplasms (Head and Neck Cancer)
10/2022
1Carcinoma (Carcinomatosis)
10/2022
1Infections
08/2022
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
08/2022
1Diabetic Retinopathy (Retinopathy, Diabetic)
07/2022
1Airway Remodeling
06/2022
1Communicable Diseases (Infectious Diseases)
05/2022
1Low Vision (Subnormal Vision)
04/2022
1Macular Degeneration (Age-Related Maculopathy)
04/2022
1Postoperative Pain
01/2022
1Unstable Angina
01/2022

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
10/2022 - 02/2008
12Pharmaceutical PreparationsIBA
03/2022 - 05/2009
8Biomarkers (Surrogate Marker)IBA
07/2022 - 01/2019
7MicroRNAs (MicroRNA)IBA
01/2022 - 01/2012
5Biological ProductsIBA
11/2021 - 01/2012
5DNA (Deoxyribonucleic Acid)IBA
10/2021 - 01/2019
4Messenger RNA (mRNA)IBA
06/2022 - 10/2013
4CytokinesIBA
11/2021 - 01/2019
4Indicators and Reagents (Reagents)IBA
05/2021 - 01/2020
4Transcription Factors (Transcription Factor)IBA
01/2021 - 10/2013
3Doxorubicin (Adriamycin)FDA LinkGeneric
09/2022 - 10/2021
3MicellesIBA
12/2021 - 11/2018
3Phosphates (Orthophosphate)IBA
01/2021 - 01/2019
3Nucleic AcidsIBA
01/2021 - 01/2018
3AutoantibodiesIBA
07/2020 - 11/2019
3Small Interfering RNA (siRNA)IBA
07/2017 - 03/2016
3fibroblast growth factor 21IBA
07/2017 - 12/2015
3Estrogen ReceptorsIBA
01/2012 - 09/2009
2Estrogens (Estrogen)FDA Link
12/2022 - 04/2011
2Peptides (Polypeptides)IBA
10/2022 - 11/2019
2Annexin A5IBA
07/2022 - 03/2022
2Tyrosine Kinase InhibitorsIBA
01/2022 - 01/2021
2ChemokinesIBA
11/2021 - 07/2020
2Anti-Citrullinated Protein AntibodiesIBA
01/2021 - 11/2019
2AntioxidantsIBA
01/2021 - 01/2017
2Ion Channels (Ion Channel)IBA
01/2021 - 01/2020
2CalciumIBA
01/2021 - 01/2020
2EnzymesIBA
01/2020 - 01/2013
2Peptide Hydrolases (Proteases)FDA Link
01/2020 - 08/2014
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020 - 01/2019
2Amino AcidsFDA Link
01/2019 - 08/2014
2HMGB1 Protein (HMG1)IBA
07/2017 - 03/2016
2Complex MixturesIBA
12/2016 - 11/2016
2jianpi jieduIBA
12/2016 - 11/2016
2Sp Transcription FactorsIBA
07/2012 - 05/2009
2Polychlorinated Dibenzodioxins (TCDD)IBA
01/2012 - 09/2009
2Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
01/2012 - 09/2009
26-methyl-1,3,8-trichlorodibenzofuranIBA
01/2012 - 09/2009
1Drug CombinationsIBA
09/2022
1trachelosideIBA
09/2022
1Urea (Carbamide)FDA LinkGeneric
08/2022
1Carbon-13IBA
08/2022
1Angiopoietin-1IBA
07/2022
1Angiopoietin-2IBA
07/2022
1SincalideFDA Link
07/2022
1CoffeeFDA Link
07/2022
1caffeic acidIBA
07/2022
1InterleukinsIBA
06/2022
1Anti-Bacterial Agents (Antibiotics)IBA
05/2022
1nuciferineIBA
03/2022
1Cisplatin (Platino)FDA LinkGeneric
03/2022
1NF-kappa B (NF-kB)IBA
01/2022

Therapy/Procedure

18Therapeutics
07/2022 - 01/2012
9Drug Therapy (Chemotherapy)
09/2022 - 10/2008
4Precision Medicine
01/2021 - 01/2018
2Immunotherapy
01/2021 - 01/2021
2Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2020 - 10/2019
2Photochemotherapy (Photodynamic Therapy)
11/2019 - 01/2019
1Hepatectomy
08/2022
1Diet Therapy (Therapy, Diet)
07/2022
1Psychology Biofeedback (Biofeedback)
04/2022
1Anesthesia
01/2022